Thus, further clarification of the status of the miR-146a-Smad4 axis in clinical osteoporosis patients or in an ovariectomized mouse model would shed light on targeting this axis as a potential therapeutic strategy. The gene discussed is SMAD4; the disease is osteoporosis.